Timing Immunotherapy Ahead of Spring Allergy Season: A Clinical Checklist

Allergen immunotherapy doesn't turn on the day it starts. Induction protocols gradually increase allergen concentration over weeks to months before a patient reaches a maintenance dose, and clinical benefit typically follows a similar timeline. For patients with a strong seasonal component, when treatment starts matters almost as much as what treatment is chosen.

The Timing Problem

A patient who begins induction in April, right as tree and grass pollen are already climbing, spends the worst weeks of the season still in the early induction phase, before the treatment has had time to meaningfully shift the immune response. That patient (and owner) may reasonably conclude the treatment "didn't work," when the real issue was timing.

Planning Backward From the Season

For clients in regions with a predictable spring pollen season, working backward from the expected onset (rather than starting whenever the case happens to come in) gives induction a real head start. Practical checkpoints worth building into the visit schedule ahead of season:

• Testing and formulation lead time. Allergy testing, formulation preparation, and any compounding or ordering lead time should be accounted for well before symptom onset is expected, not once it's already begun.
• Induction runway. Confirm how long the specific product's induction schedule takes to reach maintenance dosing, and count backward from expected season onset.
• Concurrent symptom control. If a patient is presenting mid-flare and testing/formulation will take time, decide up front what's being used to manage symptoms during that window, separate from the immunotherapy plan itself.
• Client expectation-setting. Make the timeline explicit with the owner. Explain that this season may still involve some symptom management while the induction phase catches up, and the fuller benefit is expected in subsequent seasons.

Why This Is Worth Building Into Practice Workflow

Clients who understand upfront that immunotherapy is a multi-month investment, timed deliberately ahead of a season, tend to have more realistic expectations and better follow-through than clients who start treatment mid-flare expecting a fast turnaround. Framing the timing conversation early is as much a compliance tool as it is a clinical one.

Don't Forget Fall-Trigger Patients on a Different Clock

Spring pollen gets most of the seasonal-timing attention, but the same backward-planning logic applies to patients whose flares cluster around fall instead: ragweed, mold spores off decomposing leaves, and rising indoor dust mite populations as homes seal up for the season. A patient whose case history points to an August-through-October pattern needs induction planned from a late-spring or early-summer visit, on the same logic as a spring-flaring patient starting in winter. It's worth checking a new atopic case's seasonal history specifically rather than defaulting to "start now and see". The planning window looks different depending on which season the patient is actually building toward.

Common Questions

What if a case presents already mid-flare, well into the season? Start testing and formulation immediately rather than waiting for the flare to resolve. Use fast-acting symptom control in the interim, and set expectations that this season's benefit may be partial while next season's is fuller.

Does delivery method affect how quickly induction can start? It can. Formats with shorter or simpler induction schedules, and without clinic-visit dependency, generally make it easier to start promptly once testing results are back. That's worth factoring in for clients with a tight seasonal window.

How far in advance should the client conversation happen? As soon as a seasonal pattern is suspected or confirmed, ideally at the visit where testing is first discussed, not after results come back.